Research Report and Overview on Bone Growth Stimulator Market, 2019

Market Scenario:

Bone Growth stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, orthopedic fixation. Bone growth stimulators works on all kinds of fractures such as fresh fractures, fractures healing slowly or not at all, fractures with an elevated risk. It can also be used as supportive therapy after surgery on a fracture and in corrective osteotomy.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6962   

Global Bone Growth Stimulator Market is expected to grow significantly over the forecast period. The market held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period.

Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. Bone growth stimulators are the perfect treatment approach when patient is not comfortable with the surgical procedure and wants to avoid it. Also, as it fastens the healing process, it helps patients get back to their feet quickly. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. Advantages over surgical procedures, faster recovery time, and increasing patient preference are some of the factors contribute to the growth of the bone growth stimulator market.

Key players:

Arthrex, Inc., Bioventus LLC, Depuy Synthes (A Subsidiary of Johnson & Johnson), DJO Finance LLC, Harvest Technologies (A Terumo BCT Company), Isto Biologics, Medtronic PLC, Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc. are some of the key players in the global bone growth stimulator market.
Segmentation:
The Global Bone Growth Stimulator Market has been segmented into Product, Application and End user.Based on products, the market has been segmented into, bone growth stimulation devices, bone morphogenetic proteins, platelet-rich plasma, and others. The bone growth stimulation devices segment is further segmented into, external bone growth stimulators, implanted bone growth stimulators, and ultrasonic bone growth stimulators among which external bone growth stimulators include pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices. The Bone Growth Stimulation Devices segment is expected to account for the largest share in the global bone growth stimulator market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other techniques.

On the basis of application, the market has been segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral and maxillofacial surgeries, and other. The spinal fusion surgeries segment is expected to account for the largest share in the global bone growth stimulator market in 2017.On the basis of end users, the market has been segmented into hospitals & clinics, home care, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global bone growth stimulator market in 2017. At the same time, the increasing establishments of the home care services in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for bone growth stimulator is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Bone Growth Stimulator Market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada. European Bone Growth Stimulator Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Bone Growth Stimulator Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone growth stimulator market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Regional Market Summary: 

Geographically, the Americas is anticipated to dominate the global bone growth stimulator market owing to the rising prevalence of the orthopaedic and spinal ailments such as bone fractures, and spinal damage among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, increasing rate of the spinal fusion procedures, growing patient population for the orthopaedic fixation procedures, high awareness among American population, high disposable income, are some of the many factors that drive the growth of the bone growth stimulator market in this region.

Europe is expected to hold the second largest market share in the global bone growth stimulator market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the bone growth stimulator market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the bone growth stimulator market during the forecast period.

Browse Complete 130 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/bone-growth-stimulator-market-6962

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

ELISpot and FluoroSpot Assay Market Volume Forecast and Value Chain Analysis 2019

ELISpot and FluoroSpot Assay are a sensitive technique used for the recognition of immune cells which specific proteins such as cytokines or antibodies. These asses are used in hospitals and research institutes for early diagnosis for diseases such as TB and other viral infection. The FluoroSpot assay is a modification of ELISpot in which combinations of monoclonal antibodies with different reagents are used to detect the infection. The key factor responsible for driving the market growth are increasing incidence of chronic diseases, rising vaccine development to solve the challenge of antimicrobial resistance, technological advancements in analyzers and ELISpot and FluoroSpot assay kits. However, the factors such as lack of skilled technicians, and alternative detection technologies may limit the market growth during the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6948         

The Global ELISpot and FluoroSpot Assay Market were estimated USD 135 million in 2017 and expected to reach USD 287 million by 2023 at a CAGR of 16.2 % during the forecast period.

Key players:

Some of the key players in the global ELISpot and FluoroSpot Assay market are Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), and Abcam (UK)Bio-Techne (US), Autoimmun Diagnostika (Germany), Biotech Investissement (France), Lophius Biosciences (Germany), and U-CyTech (Netherlands), and Others.

Segmentation:

The Global ELISpot and FluoroSpot Assay Market is segmented on the basis of product, application, and end-user. The ELISpot and FluoroSpot Assay market, by product is categorised into various assay kit, analyzer, ancillary products. The assay kit is sub-segmented into T Cell assay and B Cell assay. On the basis of application, the market is segmented into transplant, vaccines development, clinical trials, cancer treatment. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic centres, research centers, and others.

On the basis of region, the Global ELISpot and FluoroSpot Assay Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Regional Analysis:

Europe stood second largest in the ELISpot and FluoroSpot Assay market owing to the increasing number of pharmaceutical companies, rising in the development of innovative vaccines for the treatment of various viral diseases. The growing funding from government and private agencies for drug development also support the ELISpot and FluoroSpot Assay market in this region.  Asia-Pacific was estimated to be the fastest growing region for the global ELISpot and FluoroSpot Assay market in 2017. The market is expected to witness growth owing to the rising prevalence of viral infection, increasing geriatric population in this region and growing demand for ELISpot and FluoroSpot Assay in research field.

The Middle East and Africa holds the least share in the global ELISpot and FluoroSpot Assay market due to the presence of low health expenditure, lack of skilled technicians and less pharmaceutical company in this region. However, the market is expected to witness growth due to increasing research & development in the Middle East.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948

    

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Gases and Equipment Market 2019–By Identifying the Key Market Segments and Key players holding market share

Market Scenario:
Global Medical Gases And Equipment Market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 13.0 Billion in 2017 and is projected to grow at a CAGR of 7.5% during the forecast period. Medical gas is manufactured, packaged, and intended for administration to a patient during diagnosis, anesthesia, and therapy. Medical gases are the life-supporting element which gives direct influence in maintaining or saving the patient’s life. Medical gas equipment are the supply systems used by end users to provide or create or distribute medical gases in the piping system. Factors characterizing the market growth are worldwide growing geriatric population coupled with rising prevalence of chronic diseases, the presence of favorable government initiatives such as industry-friendly safety, and rising demand for home healthcare. Geriatric population is highly prone to develop chronic diseases, namely, diabetes, cancer, asthma, respiratory diseases, and cardiovascular diseases. The World Health Organization (WHO) projected worldwide population aged 60 years and above will grow from 962.0 million in 2017 to more than 2.0 billion in 2050 to 3.1 billion by 2100.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6940        
Segmentation:
The Global Medical Gases And Equipment Market has been segmented into product, application, and end user.By product, the market has been segmented into medical gases, medical gas mixtures, and medical gas equipment. The medical gases segment has been further categorized into nitrogen gas, nitrous oxide gas, oxygen gas, carbon dioxide gas, helium gas, and medical air. The medical gases segment spearheaded the market in 2017 owing to worldwide increasing patient hospitalization and a surge in the number of patients suffering from respiratory diseases.The medical gas mixtures segment is further categorized into medical laser gas mixtures, medical drug gas mixtures, sterilant gas mixtures, lung diffusion mixtures, blood gas mixtures, aerobic gas mixtures, anaerobic gas mixtures, and breathing zone monitoring calibration standard. The medical gas equipment is further categorized into air compressors, vacuum systems, flow meters, cylinders, alarm systems, masks, and others (manifolds, regulators, and outlets).
On the basis of application, the market has been segmented into therapeutic applications, diagnostic applications, pharmaceutical manufacturing & research, and others. The therapeutic applications segment is further categorized into respiratory therapies, cardiovascular therapies, anesthesia delivery, and others.Based on end user, the market has been segmented into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and home healthcare.The Global Medical Gases And Equipment Market  has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The medical gases and equipment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Medical Gases And Equipment Market has been segmented into Western Europe and Eastern Europe. The Western Europe Medical Gases And Equipment Market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.The Medical Gases And Equipment Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The medical gases and equipment market in the Middle East & Africa has been segmented into the Middle East and Africa.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/medical-gases-and-equipment-market-6940
Regional Market Summary 
Geographically, the Americas is expected to dominate the global medical gases and equipment market due to the domicile of key market participants, the presence of sophisticated healthcare infrastructure and target population, and growing elderly population & prevalence of chronic diseases such as diabetes, cancer, asthma, respiratory diseases, cardiovascular diseases, and other non-communicable diseases.Europe is also likely to hold substantial market share over the forecast period owing to the presence of various associations, namely, the MGA (Medical Gas Association) and EIGA (European Industrial Gases Association), and federations such as the European Federation of Precision Mechanical and Optical Industries EUROM.

The market in Asia-Pacific is expected to exhibit the fastest growth during the forecast period attributed to the presence of large population base in countries like China & India, improving healthcare infrastructure coupled with rising spending on healthcare.The medical gases and equipment market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.
Key players:
Atlas Copco, Air Liquide, Praxair Technology, Inc., Airgas, Inc., Messer Group GmbH, AB Matheson Tri-Gas, Inc., The Linde Group, TAIYO NIPPON SANSO CORPORATION, Amico Corporation, SCI Analytical, SOL S.p.A., Rotarex SA, GCE Holding AB, Air Products and Chemicals, Inc., and Matheson Tri-Gas, Inc. are some of the prominent players in the global medical gases and equipment market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Veterinary Imaging Market 2019 Size, Share, Trends, Opportunities, Growth Factors, Key Players, And Regional Forecast 2023 Research Report

Market Scenario

The global veterinary imaging market was valued at USD 1247.61 Mn in 2017 and is expected to surpass a valuation of USD 1800 Mn by the end of 2023.

Pet healthcare is trending globally with the focus shifting towards improving veterinary capabilities on all fronts. Veterinary imaging remains one of the key focus areas as animal care providers, veterinaries and animal research institutes increase their efforts towards developing superior veterinary imaging technologies.

The global Veterinary Imaging market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Veterinary deals with diagnosis and treatment of diseases in animals. Veterinary imaging devices are useful in diagnosis and treatment of diseases in animals. These devices also gives clear understanding of disease or injury that helps veterinarian for treatment of animal. Increasing awareness about animal healthcare and improvement of animal life are key factors for the growth of the market. Disease pattern in animals are continuously changing and becoming more challenging for veterinarians to diagnose these diseases.

Veterinary imaging devices gives them in accurate diagnosis and further treatment. Increasing pet adoption is another major factor for the growth of the market. Increasing number of veterinarians, veterinary clinics and growing veterinary healthcare infrastructure are driving the growth for the market. Cattles are very important part of farming that have economic importance because they provide many products like milk, meat and leather. Farmers are becoming more aware about the health of their cattle which is good sign for the growth of the market. About 75% of veterinarians are working in private hospitals or pet clinics and these hospitals or clinics are spending money in advancement of technology to provide better facilities.

Veterinary imaging devices manufacturers are spending money to develop innovative and usable product for the market. However there are some factors which are inhibiting the growth of the market such as high cost of devices that small clinics cannot afford, lack of knowledge about new technology or products, availability of products, access to veterinary healthcare facilities, lack of skilled veterinary professionals etc.

Report Coverage

Value, Market Share, Player Analysis, value chain analysis, Porter's five forces model, demand & supply: gap analysis, investment opportunities analysis, pricing analysis, technological trends, country level break down for product type, animal type, therapeutic area, end-user.

Competitive Tracking

Key players in the global veterinary imaging market that have been analyzed in the report include Fujifilm Holding Corporation, Heska Corporation, Idexx Laboratory Inc, and Canon. Other players include Hallmarq Veterinary Imaging Ltd., Carestream Health, General Electric and others. Market strategies most employed by these competitors include product innovation and investments in R&D pipeline.

Regional Analysis

Led by North America, The Americas have the largest share of the global market. The region is witnessing a rising demand for pet insurance as pet owners are becoming more invested in their pets’ health. The rapid adoption of innovative technology offerings in the region is responsible for its leading position in the veterinary imaging market. Europe, with its inclusion of developed countries such as Germany, France, and the U.K. accounts for the second largest market share due to the presence of prominent market players and supportive government initiatives toward pet insurance and pet healthcare.

The Asia-Pacific is set to grow at the most rapid pace with countries such as Japan, China, and India taking the lead. The growing prevalence of nuclear families with a tendency toward pet adoption and increasing investments in pet care have prompted international players to establish their presence in these countries in an effort to tap the potential this region carries.

Browse Complete 138 Pages Premium Research Report Enabled with 171 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Chemotherapy Market: Industry Size, Trends and Analysis - Growth Revenue And Cost Analysis With Key Company's Profiles, Forecast To 2023

Market Scenario:

According to the analysis offered by Market Research Future (MRFR), the global chemotherapy market has been presumed to strike a CAGR of 6.2% during the forecast period 2017 to 2023. Chemotherapy is an effective treatment for cancer which infuses drugs into the bloodstream to target specific cancer sites. The growth trajectory of the market is anticipated to be dominated by the rising burden of the disease.

Chemotherapy is excessively used for the treatment of different types of cancer such as lung cancer, bone cancer, blood cancer, etc. The technological advancements in the treatment are further expected to boost the future trajectory of the chemotherapy market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5791

Emphasis is placed on research & development for bringing more precision and effectiveness. It is prognosticated to have a favorable impact on the expansion of the chemotherapy market. On the flip side, factors such as the high cost of treatment and poor reimbursement policies remain impediments to the market growth. In addition, the side effects of the treatment such as hair loss, hearing impairment, alopecia, etc. are projected to further hinder the proliferation of the chemotherapy market in the upcoming years.

Competitive Dashboard:

Some of the key players profiled in this MRFR report are Sanofi (France), Eli Lilly & Company (U.S.), GlaxoSmithKline (U.K.), Novartis (Germany), Pfizer Inc. (U.S.), ImClone Systems Inc. (U.S.), AstraZeneca (U.K), Schering-Plough (U.S.), Bristol-Myers Squibb , Teva Pharmaceuticals Industries (Japan), F. Hoffmann-La Roche Ltd ( Switzerland), Boehringer Ingelheim (Germany), Merck & Co., Inc. (U.S.), CELGENE CORPORATION (U.S.), Amgen Inc (U.S.), Chemo Espana SL (Spain), Bayer AG (Germany), and Takeda Pharmaceutical Company Limited (Japan).

Industry News:

In May 2018, Advanced Chemotherapy Technologies, North Carolina, has started working on large coin-sized implant for delivering chemo agents into the pancreas.

In September 2018, Alan B. Pearson Regional Cancer Center in Lynchburg announced the installation of Dignicap Cooling System that cools down the scalp by 37 degrees for preventing hair loss during chemotherapy.

In December 2018, a team of experts is reported to work on the development of dry powder for inhaled chemotherapy. The Belgian spin-off project, InhaTarget Therapeutics, aims at treating lung cancer locally.

Market Segmentation:

On the basis of drugs, the global chemotherapy market has been segmented into anti-tumor antibiotics, topoisomerase inhibitors, alkylating agents, antimetabolites, mitotic inhibitors, and others. The alkylating agents segment has been further sub-segmented into mustard gas derivatives, ethylenimines, alkyl sulfonates, hydrazines and triazines, and others. The anti-tumor antibiotics segment is further sub-segmented into anthracyclines and chromomycin. The topoisomerase inhibitors segment has been sub-segmented into Topoisomerase I inhibitors and Topoisomerase II inhibitors.

On the basis of indication, the chemotherapy market has been segmented into lymphoma, leukemia, breast cancer, lung cancer, myeloma, ovarian cancer, sarcoma, and others.

On the basis of the route of drug administration, the global chemotherapy market has been segmented into oral and intravenous.

On the basis of end-user, the chemotherapy market has been segmented into hospitals, research institutes, and others.

Regional Analysis:

By region, the global chemotherapy market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is expected to thrive significantly in the foreseeable future. The rising burden of cancer is poised to dive the expansion of the chemotherapy market in the region over the assessment period. Other factors that are likely to propel the expansion of the regional market are changing lifestyle, advancements in healthcare, rising healthcare expenditure, etc.

Europe is projected to witness considerable growth owing to the availability of funds and government support for research & development. Also, Asia Pacific is likely to flourish during the projection period due to rapid developments in the healthcare sector. It is estimated to strike a comparatively higher CAGR across the review period. Meanwhile, the Middle East & Africa resonates growth opportunities owing to the increasing awareness about the disease.

Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/chemotherapy-market-5791

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Autoimmune Disease Treatment Market 2019 Global Size, Share, Trends, Growth, And Regional Forecast 2023Research Report

Definite causes for the development of autoimmune diseases have not been identified. Thus, the emphasis is on the early diagnosis of the disease. Increasing awareness coupled with large-scale prevalence is likely to aid the proliferation of the autoimmune disease treatment market in the foreseeable future.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5586

Expenditures for the treatment of these diseases are on the rise and is poised to exhibit a similar trend in the forthcoming years. As per the National Institutes of Health (NIH), the U.S., the healthcare expenditure for autoimmune diseases has reached half of that of the cancer expenditure. Furthermore, the introduction of favorable policies for insurance reimbursements are anticipated to augment the market over the next couple of years. However, factors such as side effects, counterfeit drugs, and expensiveness of the treatment are forecasted to check the expansion of the autoimmune disease treatment market across the review period.

Autoimmune Disease Treatment Market – Segmental Analysis:

By disease type, the global autoimmune disease treatment market has been segmented into localized, and systemic. The localized segment is further sub-segmented into multiple sclerosis, inflammatory bowel disease, diabetes, and other. The systemic segment is sub-segmented into rheumatoid arthritis, psoriasis, lupus, and others.

By diagnosis, the autoimmune disease treatment market has been segmented into ELISA, dot blot, line blot, agglutination, double immune diffusion, western blotting, multiplex immunoassay, and others.

By therapeutic products, the global autoimmune disease treatment market has been segmented into drugs and therapeutic and monitoring equipment. The drugs segment is further sub-segmented into biologics, immunosuppressant, anti-inflammatory drugs, corticosteroids, and non-steroidal anti-inflammatory drugs.

By distribution channel, the autoimmune disease treatment market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.

Regional Outlook:

The Americas dominate the autoimmune disease treatment market owing to the rising cases of autoimmune diseases, and high healthcare expenditure. As per the data suggested by Centers for Disease Control and Prevention in 2015, the total healthcare expenditure in the U.S. was reported to be USD 3.2 trillion, whereas, hospital care accounted for a share of 32.3%.

Europe holds the second position in the autoimmune disease treatment market. It is expected that the financial support provided by the government bodies for research & development and amendments in reimbursement policies in the healthcare is likely to drive the European market

Owing to a huge patient pool and developing healthcare technology, Asia Pacific is the fastest growing autoimmune disease treatment market. Healthcare expenditure is also found to be escalating in various Asia Pacific countries. The Australian Institute of Health and Welfare suggested that in the year 2015-2016, the total healthcare expenditure was USD 170.4 billion, which is around 3.6% higher than the expenditure during 2014-2015.

The Middle East & Africa holds the lowest market due to poor medical facilities, and lack of technical knowledge.

Autoimmune Disease Treatment Market – Competitive Dashboard:

Some of the prominent players profiled in this MRFR report are Abbott Laboratories, Genentech Inc., Bayer Schering Pharma AG, Amgen Inc., Biogen Idec Inc., Chugai Pharmaceutical Co. Ltd., Danaher, Bio-Rad, Elan Corporation Plc, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Eli Lilly and Company, Johnson & Johnson Inc., Siemens, Squibb Company, Merck & Co. Inc., and Thermo Fisher Scientific.

Industry News:

• In January 2019, Cabaletta Bio, launched out of the University of Pennsylvania, has raised USD 50 Mn for the treatment of for cell-based autoimmune disease.
• In January 2019, Banner Life Sciences LLC, a privately held specialty pharmaceutical company, has received tentative approval by the U.S. Food and Drug Administration (FDA) for BAFIERTAM developed for the treatment of relapsing forms of Multiple Sclerosis.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586

         

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Nasal Drug Delivery Market 2019 Size, Share, Trends, Opportunities, Growth Factors, Key Players, And Regional Forecast 2023 Research Report

Market Scenario

Increasing popularity of over-the-counter nasal drugs such as inhalers for the common cold is also propel the market in an upward manner. Nasal drugs prove to be advantageous for the market, with a plethora of factors like good penetration of the drugs into the nasal cavity, improving patient compliance, rapid absorption, onset of action, and requirement of low dosage.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2696

The nasal route administration is experiencing tremendous growth due to its noninvasive nature consequently reducing pain and threat of infections. It allows the patient to self-administer drugs thus not requiring any external help. The high vasculature, high permeability, and low enzymatic environment of nasal cavity are perfectly apt for systemic delivery of drug molecules via nose. There is no risk of drug destruction by hydrogen chloride (HCl) present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. This, in turn, leads to proportional reduction in side effects.

Key Players

• Novartis AG
• Pfizer, Inc.
• Sanofi-Aventis
• Merck & Co., Inc.
• AptarGroup Inc.
• Johnson & Johnson Services, Inc.
• GlaxoSmithKline plc
• Becton Dickson & Company

Regional Analysis

UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa’s market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.

Segmentation

Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.

Drivers and Restraints

The market for nasal drug delivery is growing remarkably with a consistently good CAGR due to the benefits accompanying nasal drugs.  Other driving factors include innovation of drugs which are absorbed easily from the nasal route, innovations in advanced products which allow the delivery of precise doses and also ease of administration. However, the restraints that threaten the growth of the market are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other routes of administration. Other constraints include concurrent low popularity of the route which reduces economies of scale in producing these delivery devices and low awareness. According to an extensive report by Market Research Future (MRFR), the Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a CAGR of 8.1% from 2017 to 2022. The market was estimated to be worth USD 1 billion in 2015.

Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

         

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com